pentobarbital will decrease the extent or outcome of linagliptin by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Check. Use of alternative treatment options is strongly advised when linagliptin is usually to be administered by using a CYP3A4 inducerpentobarbital will lessen the level or impact of buprenorphine subdermal impl